Vitamin C treatment was also tested in murine IDH1 mutant leukemic cells, showing TET2-dependent 5-hmC gain, 5-mC loss, and upregulation of gene expression that correlates with decreased self-renewal of leukemia stem cells and increased differentiation towards the mature marrow phenotype [140]. The gene discussed is TET2; the disease is leukemia.